Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Cagrilintide vs Semaglutide
An educational, source-based comparison of Cagrilintide and Semaglutide — how each peptide works, what it's researched for, and what to know before going deeper.
A long-acting analog of amylin, a pancreatic hormone co-secreted with insulin. It slows gastric emptying, increases satiety, and suppresses glucagon — complementary to GLP-1 mechanisms.
- Weight management as monotherapy and combined with semaglutide (CagriSema)
- Glycemic control in type 2 diabetes
- • Investigational; not yet FDA-approved as monotherapy.
- • GI side effects similar to GLP-1 agonists.
A long-acting GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central GLP-1 receptors.
- Type 2 diabetes (Ozempic, Rybelsus)
- Obesity / chronic weight management (Wegovy)
- Cardiovascular risk reduction (SELECT trial)
- • FDA-approved with established safety profile but real side effects (GI, pancreatitis risk, gallbladder events).
- • Requires physician oversight and prescription.
- • Compounded versions vary in quality.
Cagrilintide vs Semaglutide — Key differences
- Class: Cagrilintide is classified as Metabolic · Amylin, while Semaglutide is Metabolic · Incretin.
- Primary research focus: Cagrilintide — weight management as monotherapy and combined with semaglutide (cagrisema); Semaglutide — type 2 diabetes (ozempic, rybelsus).
- Tag: Weight loss vs Weight loss.